Hematology - Featured Archives - Insights

Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots

jgilligan1 — Fri, 22 Nov 2024 14:10:52 +0000

Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.

The post Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots appeared first on Insights.

Dr. Dong Chen and Dr. Sounak Gupta join Becker’s Healthcare Podcast to discuss molecular testing in cancer care

jgilligan1 — Tue, 29 Oct 2024 01:00:00 +0000

Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the right molecular tests for patients, the impact of genetic testing on cancer diagnosis and treatment, and how Mayo Clinic Laboratories is helping physicians make informed decisions for the best patient outcomes.

The post Dr. Dong Chen and Dr. Sounak Gupta join Becker’s Healthcare Podcast to discuss molecular testing in cancer care appeared first on Insights.

The Science of Diagnosing Rare Platelet Disorders: Dong Chen, M.D., Ph.D.

Luci Gens — Thu, 03 Oct 2024 13:00:00 +0000

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Dong Chen, M.D., Ph.D., chair of the Division of Hematopathology in the Department of Laboratory Medicine and Pathology at Mayo Clinic. They discuss rare and inherited platelet disorders and esoteric laboratory testing of hematologic disorders.

The post The Science of Diagnosing Rare Platelet Disorders: Dong Chen, M.D., Ph.D. appeared first on Insights.

Clinical Updates on Thrombotic Thrombocytopenic Purpura (TTP)

MCL Education — Fri, 06 Sep 2024 10:00:00 +0000

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., interviews Ewa Wysokinska, M.D., an assistant professor of medicine and consultant in the division of hematology and oncology at Mayo Clinic in Florida, to talk about clinical updates in thrombotic thrombocytopenic purpura.

The post Clinical Updates on Thrombotic Thrombocytopenic Purpura (TTP) appeared first on Insights.

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

Barbara J. Toman — Tue, 30 Apr 2024 13:00:00 +0000

David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the syndrome, which severely impacts multiple organs and blood.

The post Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D. appeared first on Insights.

Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.

Barbara J. Toman — Tue, 06 Feb 2024 14:30:00 +0000

David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler test ordering.

The post Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D. appeared first on Insights.

FISH testing helps detect unseen cancer cells: Shannon Camlek

Chris Bahnsen — Mon, 08 Jan 2024 14:00:00 +0000

On the brink of losing her battle with acute myeloid leukemia, Shannon Camlek arrived at Mayo Clinic as a last hope. Her chances didn’t look good, but with the help of specialized genetic testing, particularly FISH (fluorescence in situ hybridization) studies, doctors were able to detect the specific gene mutations responsible for her symptoms and disease. The test results also helped Shannon’s care team target her treatment accordingly, and finally put an end to what Shannon likens as starring in her own personal horror movie while in search of hope and healing.

The post FISH testing helps detect unseen cancer cells: Shannon Camlek appeared first on Insights.

Unveiling a novel hemoglobinopathy classification

Nicole Holman — Wed, 11 Oct 2023 13:00:00 +0000

In a recent discovery by Mayo Clinic Laboratories, a novel hemoglobinopathy category was identified and termed epsilon gamma thalassemia. The first instance of the disorder was found in 2017 when an obstetric patient underwent a routine screening for blood-related illnesses such as sickle cell disease and thalassemia. Upon completion of additional tests, doctors found an abnormality they had never seen before.

The post Unveiling a novel hemoglobinopathy classification appeared first on Insights.

NGS for Myeloid Neoplasm Evaluation

MCL Education — Mon, 24 Oct 2022 10:00:00 +0000

In this month's "Hot Topic," David Viswanatha, M.D., discusses updates to Mayo Clinic's next-generation sequencing (NGS) for myeloid neoplasm evaluation, involving new test targets, the rationale for new genetic regions, alignments with the World Health Organization (WHO) guidelines and germline predisposition targets.

The post NGS for Myeloid Neoplasm Evaluation appeared first on Insights.